Literature DB >> 18677617

Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice.

Jessica N Cleck1, Laurel E Ecke, Julie A Blendy.   

Abstract

RATIONALE: Stress can reinstate previous cocaine-seeking long after drug is no longer present. However, little is known regarding the effect of chronic drug exposure and subsequent drug abstinence on responsivity to stress.
OBJECTIVE: To determine the effect of acute (24-h) and prolonged (14-day) drug-free periods in cocaine-experienced mice on behavioral, endocrine, and molecular outputs following stress exposure.
MATERIALS AND METHODS: Mice were administered a cocaine binge (15 mg/kg, every hour for 3h) for 2 weeks. Following a 24-h or 14-day drug-free period, stress responsivity, along with levels of anxiety, were measured using the forced swim test and elevated zero maze, respectively. In addition, alterations in the levels of plasma corticosterone, corticotrophin-releasing factor (CRF) mRNA, brain-derived neurotrophic factor (BDNF) mRNA, and histone acetylation at their respective promoters were examined following stress exposure.
RESULTS: At both acute and prolonged abstinence time points, behavioral measures were essentially unaltered; however, cocaine-experienced mice exhibited an augmented corticosterone response to the forced swim stress compared to saline-treated mice. Stress exposure increased BDNF mRNA levels in the ventral tegmental area (VTA) and nucleus accumbens (NAc) only in cocaine-experienced mice following a prolonged, but not acute, drug-free period. Increased BDNF mRNA in the NAc was associated with an increase in acetylated histone 3 (AcH3) at the BDNF I promoter. CRF mRNA levels were increased in the amygdala (AMYG); however, this was not associated with alterations in histone acetylation at the promoter.
CONCLUSION: These results demonstrate that drug history and prolonged abstinence can alter the endocrine and molecular responses to stress, which may facilitate the reinstatement of drug-seeking behaviors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677617      PMCID: PMC4010951          DOI: 10.1007/s00213-008-1243-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  65 in total

1.  Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.

Authors:  L Lu; D Liu; X Ceng
Journal:  Eur J Pharmacol       Date:  2001-03       Impact factor: 4.432

2.  Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats.

Authors:  J B Richards; K E Sabol; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

3.  Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior.

Authors:  J D Shepard; K W Barron; D A Myers
Journal:  Brain Res       Date:  2000-04-10       Impact factor: 3.252

4.  Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus.

Authors:  Amrita Nair; Krishna C Vadodaria; Sunayana B Banerjee; Madhurima Benekareddy; Brian G Dias; Ronald S Duman; Vidita A Vaidya
Journal:  Neuropsychopharmacology       Date:  2006-12-13       Impact factor: 7.853

5.  Brain chromatin remodeling: a novel mechanism of alcoholism.

Authors:  Subhash C Pandey; Rajesh Ugale; Huaibo Zhang; Lei Tang; Anand Prakash
Journal:  J Neurosci       Date:  2008-04-02       Impact factor: 6.167

6.  Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.

Authors:  Frederick A Schroeder; Krista L Penta; Anouch Matevossian; Sara R Jones; Christine Konradi; Andrew R Tapper; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

7.  Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats.

Authors:  John R Mantsch; David A Baker; David M Francis; Eric S Katz; Michael A Hoks; Joseph P Serge
Journal:  Psychopharmacology (Berl)       Date:  2007-09-26       Impact factor: 4.530

8.  Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration.

Authors:  Willard M Freeman; Kruti M Patel; Robert M Brucklacher; Malinda E Lull; Mandi Erwin; Drake Morgan; David C S Roberts; Kent E Vrana
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

9.  Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse.

Authors:  Danielle L Graham; Scott Edwards; Ryan K Bachtell; Ralph J DiLeone; Maribel Rios; David W Self
Journal:  Nat Neurosci       Date:  2007-07-08       Impact factor: 24.884

10.  Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat.

Authors:  Shane A Perrine; Imran S Sheikh; Chinwe A Nwaneshiudu; Joseph A Schroeder; Ellen M Unterwald
Journal:  Neuropharmacology       Date:  2007-10-22       Impact factor: 5.250

View more
  29 in total

1.  Depressive phenotypes evoked by experimental diabetes are reversed by insulin.

Authors:  Nancy Ho; Darrick T Balu; Monica R F Hilario; Julie A Blendy; Irwin Lucki
Journal:  Physiol Behav       Date:  2011-09-10

2.  Regulation of hippocampal H3 histone methylation by acute and chronic stress.

Authors:  Richard G Hunter; Katharine J McCarthy; Thomas A Milne; Donald W Pfaff; Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

Review 3.  Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants.

Authors:  Florian Duclot; Mohamed Kabbaj
Journal:  J Exp Biol       Date:  2015-01-01       Impact factor: 3.312

Review 4.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

5.  Beta-2 adrenergic receptors mediate stress-evoked reinstatement of cocaine-induced conditioned place preference and increases in CRF mRNA in the bed nucleus of the stria terminalis in mice.

Authors:  Jayme R McReynolds; Oliver Vranjkovic; Malia Thao; David A Baker; Khadijah Makky; Yiwei Lim; John R Mantsch
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

6.  Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes.

Authors:  Zivjena Vucetic; Jessica Kimmel; Kathy Totoki; Emily Hollenbeck; Teresa M Reyes
Journal:  Endocrinology       Date:  2010-08-04       Impact factor: 4.736

7.  A role for repressive histone methylation in cocaine-induced vulnerability to stress.

Authors:  Herbert E Covington; Ian Maze; HaoSheng Sun; Howard M Bomze; Kristine D DeMaio; Emma Y Wu; David M Dietz; Mary Kay Lobo; Subroto Ghose; Ezekiel Mouzon; Rachael L Neve; Carol A Tamminga; Eric J Nestler
Journal:  Neuron       Date:  2011-08-25       Impact factor: 17.173

8.  Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study.

Authors:  Carrol D'Sa; Helen C Fox; Adam K Hong; Ralph J Dileone; Rajita Sinha
Journal:  Biol Psychiatry       Date:  2011-07-08       Impact factor: 13.382

Review 9.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

Review 10.  Epigenetics and psychostimulant addiction.

Authors:  Heath D Schmidt; Jacqueline F McGinty; Anne E West; Ghazaleh Sadri-Vakili
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.